首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

臨床試驗診斷影像市場規模、佔有率和成長分析（按服務/軟體、模式、治療領域、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1897876

臨床試驗診斷影像市場規模、佔有率和成長分析（按服務/軟體、模式、治療領域、最終用戶和地區分類）—產業預測（2026-2033 年）

Clinical Trial Imaging Market Size, Share, and Growth Analysis, By Service and Software (Service, Software), By Modality (Computed Tomography, Magnetic Resonance Imaging), By Therapeutic Area, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 194 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，臨床試驗診斷影像市場規模將達到 14.2 億美元，到 2025 年將達到 15.3 億美元，到 2033 年將達到 28 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.82%。

臨床試驗影像市場預計將迎來強勁成長，這主要得益於生物技術和製藥產業的擴張，這兩個產業正大力投資研發標靶治療。此外，對醫學影像公司投資的增加以及將先進影像技術整合到醫療設備研究中的策略性併購也推動了這一成長。技術進步提高了臨床試驗影像資料的擷取、分析和呈現方式，影像分析軟體具有準確性、一致性和擴充性等優勢。此外，計算技術的日益普及也進一步提升了臨床試驗影像的程度。定量影像生物標記聯盟（QIBA）已建立標準化方法，以確保可靠且統一的數據收集，有助於改善試驗結果。

臨床試驗影像市場促進因素

臨床試驗影像市場主要受製藥和生物技術領域研發投入不斷成長的推動。隨著藥物研發過程日益複雜，對用於監測臨床試驗期間治療效果和疾病進展的先進影像技術的需求也日益成長。諸如磁振造影（MRI）、正子斷層掃描（PET）和電腦斷層掃描）等先進影像技術，能夠提供關於新型治療方法安全性和有效性的關鍵數據，從而促進其在科學研究中的評估。這一趨勢凸顯了先進影像技術在確保新型醫療方法和治療方案成功方面所發揮的關鍵作用。

臨床試驗影像市場的限制因素

臨床試驗影像市場的一大障礙是先進影像技術（例如MRI、PET和電腦斷層掃描）的高昂成本。這些成本顯著增加了臨床試驗的整體預算，為中小型製藥公司和研究機構取得這些關鍵資源帶來了挑戰。此外，對放射科醫生和其他影像專家等專業人員的需求也為臨床試驗帶來了額外的經濟負擔，並阻礙了先進影像技術在研究活動中的廣泛應用。因此，這些因素限制了先進影像解決方案在臨床試驗中的潛在應用。

臨床試驗影像診斷市場趨勢

臨床試驗影像市場的一大趨勢是人工智慧 (AI) 和機器學習技術與診斷影像系統的融合日益增強。這些 AI 驅動的工具提高了影像分析的準確性和效率，顯著降低了人為錯誤的機率，並加快了結果報告速度。透過自動化複雜的影像處理任務，AI 簡化了臨床診斷流程，使診斷影像解決方案更易於取得且更具成本效益。這項技術進步不僅能夠實現更快、更可靠的數據解讀，還有助於臨床決策支持，反映出人們越來越依賴先進的診斷影像技術來最佳化臨床試驗結果。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

ICON plc
Medpace
Clario
IXICO plc
Resonance Health Ltd.
Radiant Sage
WCG Clinical
Medical Metrics, Inc.
Prism Clinical Imaging
Boston Imaging Core Lab
Voiant
Calyx
Biospective Inc.
Micron, Inc.
Imaging Endpoints
Perspectum
Competence Network Life Sciences（Pharmtrace）
Median Technologies
Image Core Lab
Image Analysis Group（IAG）

簡介目錄

Product Code: SQMIG35H2309

Clinical Trial Imaging Market size was valued at USD 1.42 Billion in 2024 and is poised to grow from USD 1.53 Billion in 2025 to USD 2.8 Billion by 2033, growing at a CAGR of 7.82% during the forecast period (2026-2033).

The clinical trial imaging market is poised for robust growth, primarily fueled by the expanding biotechnology and pharmaceutical sectors, which are significantly investing in research and development to create targeted therapies. This growth is also driven by increased investments in medical imaging companies and strategic mergers and acquisitions that integrate advanced imaging technologies for medical device investigations. Technological advancements have enhanced the collection, analysis, and presentation of clinical trial imaging data, with image analysis software providing advantages such as accuracy, consistency, and scalability. Additionally, the greater adoption of computing technologies offers further improvements in clinical trial imaging. The Quantitative Imaging Biomarker Alliance (QIBA) has established standardized methods, ensuring reliability and uniformity in data collection for enhanced trial outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trial Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trial Imaging Market Segments Analysis

Global Clinical Trial Imaging Market is segmented by Service and Software, Modality, Therapeutic Area, End User, and Region. Based on Service and Software, the market is segmented into Services (Operational Imaging Services, Read Analysis Services, System And Technical Support Services, Trial Design And Consulting Services), Software. Based on Modality, the market is segmented into Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Others. Based on Therapeutic Area, the market is segmented into Oncology, Infectious Diseases, Neurology, Cardiovascular System Disorders, Endocrinology, Immunological Disorders, Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic And Government Research Institutes, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trial Imaging Market

The clinical trial imaging market is significantly driven by the rising investments in research and development within the pharmaceutical and biotechnology sectors. As the process of drug development becomes increasingly complex, there is a growing demand for precise imaging technologies to monitor treatment effects and disease progression during clinical trials. Advanced imaging modalities, including MRI, PET, and CT scans, provide essential data regarding the safety and effectiveness of new therapies, facilitating their evaluation in scientific studies. This trend highlights the critical role of advanced imaging in ensuring the success of new medical treatments and therapies.

Restraints in the Clinical Trial Imaging Market

A significant barrier in the Clinical Trial Imaging market is the elevated costs associated with sophisticated imaging technologies such as MRI, PET, and CT scans. These expenses can substantially escalate the overall budget of clinical trials, posing challenges for smaller pharmaceutical companies and research institutions in accessing these crucial resources. Furthermore, the need for specialized professionals, including radiologists and other imaging experts, adds an additional layer of financial strain, deterring the widespread implementation of advanced imaging in research activities. Consequently, these factors contribute to limiting the potential application of advanced imaging solutions within clinical trials.

Market Trends of the Clinical Trial Imaging Market

A prominent trend in the clinical trial imaging market is the increasing integration of Artificial Intelligence (AI) and machine learning technologies into imaging systems. These AI-driven tools enhance the accuracy and efficiency of image analysis, significantly reducing the potential for human error and accelerating result turnaround times. By automating intricate imaging tasks, AI streamlines the clinical diagnostic process, thereby enhancing accessibility and cost-effectiveness in imaging solutions. This technological evolution not only facilitates quicker and more reliable data interpretations but also supports clinical decision-making, reflecting a growing reliance on advanced imaging technologies to optimize clinical trial outcomes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Patent Analysis
Pricing Analysis
Trade Analysis
Value Chain Analysis
Supply Chain Analysis
Customer & Buying Criteria Analysis
Case Study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Clinical Trial Imaging Market by Service and Software

Market Overview
Services
- Operational Imaging Services
- Read Analysis Services
- System & Technical Support Services
- Trial Design & Consulting Services
Software

Clinical Trial Imaging Market by Modality

Market Overview
Computed Tomography
Magnetic Resonance Imaging
Ultrasound
Positron Emission Tomography
X-Ray
Others

Clinical Trial Imaging Market by Therapeutic Area

Market Overview
Oncology
Infectious Diseases
Neurology
Cardiovascular System Disorders
Endocrinology
Immunological Disorders
Others

Clinical Trial Imaging Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Medical Device Manufacturers
Contract Research Organizations
Academic And Government Research Institutes
Others

Clinical Trial Imaging Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clario
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IXICO plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Resonance Health Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Radiant Sage
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WCG Clinical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medical Metrics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prism Clinical Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Imaging Core Lab
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Voiant
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Calyx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biospective Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micron, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imaging Endpoints
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perspectum
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Competence Network Life Sciences (Pharmtrace)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Median Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Image Core Lab
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Image Analysis Group (IAG)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments